Find a Doctor or Practice Location

Are you a referring physician?
within
I am searching for a
Reset Form
Edward A. Stadtmauer, MD

Edward A. Stadtmauer, MD Physician

Section Chief, Hematologic Malignancies Roseman, Tarte, Harrow, and Shaffer Families' President's Distinguished Professor

Dr. Stadtmauer is employed by Penn Medicine.

About Dr. Edward A. Stadtmauer

Recognized by America's Top Doctors, 2007, 2008, 2010, 2011 - 2018

Recognized by Best Doctors in America 2003 - 2018

Recognized in Philadelphia magazine's annual Top Docs issues from 2005 - 2008, 2011, and 2013 - 2018

Patient Satisfaction Ratings

Patient Rating Breakdown

The Patient Satisfaction Rating is an average of all responses to the care provider related questions shown below from our nationally-recognized Press Ganey Patient Satisfaction Survey. Patients that are treated in outpatient or hospital environments may receive different surveys, and the volume of responses will vary by question.

Responses are measured on a scale of 1 to 5 with 5 being the best score.

Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

Overall Ratings

Clinical Specialties

Specialty:

  • Hematology
  • Medical Oncology

Programs & Centers:

Board Certification:

  • Hematology, 1988
  • Internal Medicine, 1986
  • Medical Oncology, 1989

Clinical Expertise:

  • Autologous Stem Cell Transplantation
  • Blood Cancer
  • Bone Marrow Transplant
  • Multiple Myeloma
  • Stem Cell Transplant

Description of Clinical Expertise

Myeloma, Leukemia, Lymphoma and Bone Marrow and Stem Cell Transplant

Practice Locations and Appointments

Insurance Accepted

  • Aetna US Healthcare
  • Amerihealth Caritas
  • Amerihealth Caritas Medicare
  • Cigna
  • Cigna HealthSpring
  • Clover Health Plan
  • CVS Health
  • Devon Health Services (Americare)
  • eLAP Services
  • Gateway Health Plan
  • Geisinger Health Plan
  • HealthAmerica / HealthAssurance, a Coventry Plan
  • HealthPartners
  • HealthPartners Medicare
  • HealthSmart
  • Highmark Blue Shield
  • Horizon Blue Cross Blue Shield of New Jersey
  • Humana / Choicecare
  • Independence Blue Cross (Keystone East)
  • Intergroup
  • Keystone First
  • Keystone First Medicare
  • Multiplan
  • NJ Medicaid
  • NJ Qualcare
  • Oxford Health Plan
  • PA Health and Wellness (Centene) Medicare
  • PA Medicaid
  • PA Medicare
  • Preferred Health Care/LGH
  • Provider Partners Health Plan
  • Rail Road Medicare / Palmetto GBA
  • Remedy Partners at Penn Medicine
  • Tricare
  • United Healthcare
  • UnitedHealthcare Community Plan
  • US Family Health Plan
  • Veterans Choice Program

Education and Training

Medical School: University of Pennsylvania School of Medicine
Residency: Bronx Municipal Hospital - Albert Einstein College
Fellowship: Hospital of the University of Pennsylvania

Memberships

American College of Physicians, Fellow, National American Federation for Clinical Research, National American Society for Blood and Marrow Transplantation, National American Society of Clinical Oncology, National American Society of Hematology, National Autologous Bone Marrow Transplant Registry (ABMTR/CIBMTR), National Bone Marrow Transplant Clinical Trials Network, National Eastern Cooperative Oncology Group, National Foundation for the Accreditation of Hematopoietic Cell Therapy, National International Myeloma Working Group, International Membership in External Advisory Committees, Endpoint Review Committees, and Data Safety and Monitoring Boards, International Membership in National Scientific Review Panels, National NCI Myeloma Steering Committee, National NIAID Hematopoietic Stem Cell Transplantation Data Safety Monitoring Board (HSCT DSMB), National

Hospital Affiliation

Dr. Stadtmauer is employed by Penn Medicine.

Hospital Privileges:

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.

Research

Description of Research Expertise:

Clinical trials, Bone Marrow Transplant

Selected Publications:

Reshef Ran, Ganetsky Alex, Acosta Edward P, Blauser Robin, Crisalli Lisa, McGraw Jessica, Frey Noelle V, Hexner Elizabeth O, Hoxie James A, Loren Alison W, Luger Selina M, Mangan James, Stadtmauer Edward A, Mick Rosemarie, Vonderheide Robert H, Porter David L: Extended CCR5 Blockade for Graft-Versus-Host Disease Prophylaxis Improves Outcomes of Reduced Intensity Unrelated Donor Hematopoietic Cell Transplantation: A Phase II Clinical Trial. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation : 2018.

Ganetsky Alex, Han Jennifer H, Hughes Mitchell E, Babushok Daria V, Frey Noelle V, Gill Saar I, Hexner Elizabeth O, Loren Alison W, Luger Selina M, Mangan James K, Martin Mary Ellen, Smith Jacqueline, Freyer Craig W, Gilmar Cheryl, Schuster Mindy, Stadtmauer Edward A, Porter David L: Oral vancomycin prophylaxis is highly effective in preventing Clostridium difficile infection in allogeneic hematopoietic cell transplant recipients. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America : 2018.

Micallef Ivana N, Stiff Patrick J, Nademanee Auayporn P, Maziarz Richard T, Horwitz Mitchell E, Stadtmauer Edward A, Kaufman Jonathan L, McCarty John M, Vargo Rita, Cheverton Peter D, Struijs Martin, Bolwell Brian, DiPersio John F: Plerixafor Plus Granulocyte Colony-Stimulating Factor for Patients with Non-Hodgkin Lymphoma and Multiple Myeloma: Long-Term Follow-Up Report. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 24 (6): 1187-1195,2018.

Crisalli Lisa M, Hinkle Joanne T, Walling Christopher C, Sell Mary, Frey Noelle V, Hexner Elizabeth O, Loren Alison W, Luger Selina M, Stadtmauer Edward A, Porter David L, Reshef Ran: Higher Donor Apheresis Blood Volumes Are Associated with Reduced Relapse Risk and Improved Survival in Reduced-Intensity Allogeneic Transplantations with Unrelated Donors. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 24 (6): 1203-1208,2018.

Ganetsky Alex, Frey Noelle V, Hexner Elizabeth O, Loren Alison W, Gill Saar I, Luger Selina M, Mangan James K, Martin Mary Ellen, Babushok Daria V, Drobyski William R, Smith Jacqueline, Timlin Colleen, Freyer Craig W, Stadtmauer Edward A, Porter David L: Tocilizumab for the treatment of severe steroid-refractory acute graft-versus-host disease of the lower gastrointestinal tract. Bone marrow transplantation : 2018.

Garfall Alfred L, Stadtmauer Edward A, Hwang Wei-Ting, Lacey Simon F, Melenhorst Jan Joseph, Krevvata Maria, Carroll Martin P, Matsui William H, Wang Qiuju, Dhodapkar Madhav V, Dhodapkar Kavita, Das Rituparna, Vogl Dan T, Weiss Brendan M, Cohen Adam D, Mangan Patricia A, Ayers Emily C, Nunez-Cruz Selene, Kulikovskaya Irina, Davis Megan M, Lamontagne Anne, Dengel Karen, Kerr Naseem Ds, Young Regina M, Siegel Donald L, Levine Bruce L, Milone Michael C, Maus Marcela V, June Carl H: Anti-CD19 CAR T cells with high-dose melphalan and autologous stem cell transplantation for refractory multiple myeloma. JCI insight 3 (8): 2018.

Waxman Adam J, Clasen Suparna, Hwang Wei-Ting, Garfall Alfred, Vogl Dan T, Carver Joseph, O'Quinn Rupal, Cohen Adam D, Stadtmauer Edward A, Ky Bonnie, Weiss Brendan M: Carfilzomib-Associated Cardiovascular Adverse Events: A Systematic Review and Meta-analysis. JAMA oncology 4 (3): e174519,2018.

D'Souza Anita, Pasquini Marcelo, Logan Brent, Giralt Sergio, Krishnan Amrita, Antin Joseph, Howard Alan, Goodman Stacy, Qazilbash Muzzafar, Knust Kristin, Sahebi Firoozeh, Weisdorf Daniel, Vesole David, Stadtmauer Edward, Maloney David, Hari Parameswaran: Heavy/light chain ratio normalization prior to transplant is of independent prognostic significance in multiple myeloma: a BMT CTN 0102 correlative study. British journal of haematology 178 (5): 816-819,2017.

Bair Steven M, Strelec Lauren, Nagle Sarah J, Nasta Sunita D, Landsburg Daniel J, Mato Anthony R, Loren Alison W, Schuster Stephen J, Stadtmauer Edward A, Svoboda Jakub: Outcomes of patients with relapsed/refractory Hodgkin lymphoma progressing after autologous stem cell transplant in the current era of novel therapeutics: A retrospective analysis. American journal of hematology 92 (9): 879-884,2017.

Holstein Sarah A, Jung Sin-Ho, Richardson Paul G, Hofmeister Craig C, Hurd David D, Hassoun Hani, Giralt Sergio, Stadtmauer Edward A, Weisdorf Daniel J, Vij Ravi, Moreb Jan S, Callander Natalie S, van Besien Koen, Gentile Teresa G, Isola Luis, Maziarz Richard T, Bashey Asad, Landau Heather, Martin Thomas, Qazilbash Muzaffar H, Rodriguez Cesar, McClune Brian, Schlossman Robert L, Smith Scott E, Hars Vera, Owzar Kouros, Jiang Chen, Boyd Molly, Schultz Chelsea, Wilson Marcia, Hari Parameswaran, Shea Thomas C: Updated analysis of CALGB (Alliance) 100104 assessing lenalidomide versus placebo maintenance after single autologous stem-cell transplantation for multiple myeloma: a randomised, double-blind, phase 3 trial. The Lancet. Haematology 4 (9): e431-e442,2017.

Academic Contact Info

Division of Hematology Oncology
Perelman Center for Advanced Medicine
12th Floor, South Pavilion
Office #12-171
3400 Civic Center Blvd

Philadelphia, PA 19104
Phone: (215) 662-7910
Patient appointments: 800-789-7366 (PENN)

Related Links